Company_Context
Healthcare
Drug Manufacturers
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
1728 directional transactions in 180D
Code P purchases and code S sales are measured from 2026.02.18 — 2026.08.16.
-$820.0M
Open-market buys minus sales2026.08.13
Latest available filing16
Reporting entities in windowROTHBLATT MARTINE A
$863.9KROTHBLATT MARTINE A
$600.3MAnalysis of eligible SEC Form 4 activity for UTHR indicates a bearish 180-day signal. The selected window contains transactions from 16 distinct reporting insiders, with aggregate nominal activity of $1061.82M.
Open-market purchases minus open-market sales produce a negative net flow of $819.99M. Open-market executions represent the majority of measured nominal activity in this window, making the directional flow more representative of voluntary trading activity.
ROTHBLATT MARTINE A recorded the largest aggregate purchase volume, while ROTHBLATT MARTINE A recorded the largest aggregate sale volume. Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Healthcare
Drug Manufacturers
0
Clustered open-market purchase records in the recent filing sample.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 180D headline signal window.
Open-market selling volume ($820.85M) currently exceeds buying volume ($0.86M), indicating net liquidation by insiders.
During the last 180 calendar days, ROTHBLATT MARTINE A (Executive) recorded the largest aggregate open-market purchase volume. Total insider buying in the window is $0.86M.
During the last 180 calendar days, eligible open-market sales total $820.85M. ROTHBLATT MARTINE A recorded the largest aggregate selling volume.
Performance pending
No matured open-market transaction with calculated market windows is available in the recent sample.
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.